Performance of different rapid antigen testing strategies for SARS-CoV-2: A living rapid review
- PMID: 37424144
- DOI: 10.1111/eci.14058
Performance of different rapid antigen testing strategies for SARS-CoV-2: A living rapid review
Abstract
Background: Rapid antigen detection tests (RADTs) for SARS-CoV-2 testing offer several advantages over molecular tests, but there is little evidence supporting an ideal testing algorithm. We aimed to examine the diagnostic test accuracy (DTA) and the effectiveness of different RADT SARS-CoV-2 testing strategies.
Methods: Following PRISMA DTA guidance, we carried out a living rapid review and meta-analysis. Searches were conducted in Ovid MEDLINE® ALL, Embase and Cochrane CENTRAL electronic databases until February 2022. Results were visualized using forest plots and included in random-effects univariate meta-analyses, where eligible.
Results: After screening 8010 records, 18 studies were included. Only one study provided data on incidence outcomes. Seventeen studies were DTA reports with direct comparisons of RADT strategies, using RT-PCR as the reference standard. Testing settings varied, corresponding to original SARS-CoV-2 or early variants. Strategies included differences in serial testing, the individual collecting swabs and swab sample locations. Overall, specificity remained high (>98%) across strategies. Although results were heterogeneous, the sensitivity for healthcare worker-collected samples was greater than for self-collected samples. Nasal samples had comparable sensitivity when compared to paired RADTs with nasopharyngeal samples, but sensitivity was much lower for saliva samples. The limited evidence for serial testing suggested higher sensitivity if RADTs were administered every 3 days compared to less frequent testing.
Conclusions: Additional high-quality research is needed to confirm our findings; all studies were judged to be at risk of bias, with significant heterogeneity in sensitivity estimates. Evaluations of testing algorithms in real-world settings are recommended, especially for transmission and incidence outcomes.
Keywords: COVID-19; SARS-CoV-2 rapid antigen detection tests; self-testing; serial testing; testing strategies.
© 2023 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.
Similar articles
-
Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic.Int J Infect Dis. 2023 Oct;135:18-20. doi: 10.1016/j.ijid.2023.07.029. Epub 2023 Aug 2. Int J Infect Dis. 2023. PMID: 37536389
-
Evaluation of the Rapid Antigen Detection Test for Diagnosing SARS-CoV-2 during the COVID-19 Pandemic: Experience from a Centralized Isolation Site in Shanghai, China.Microbiol Spectr. 2023 Feb 14;11(1):e0454222. doi: 10.1128/spectrum.04542-22. Epub 2023 Jan 19. Microbiol Spectr. 2023. PMID: 36655994 Free PMC article.
-
Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS-CoV-2: A rapid review.Rev Med Virol. 2022 Sep;32(5):e2350. doi: 10.1002/rmv.2350. Epub 2022 Mar 29. Rev Med Virol. 2022. PMID: 35348276 Free PMC article. Review.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
Cited by
-
Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.Euro Surveill. 2022 Jan;27(3):2101202. doi: 10.2807/1560-7917.ES.2022.27.3.2101202. Euro Surveill. 2022. PMID: 35057900 Free PMC article.
References
REFERENCES
-
- World Health Organization. WHO coronavirus (COVID-19) dashboard. Published 2020 https://covid19.who.int/
-
- Lee RA, Herigon JC, Benedetti A, Pollock NR, Denkinger CM. Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: a systematic review and meta-analysis. J Clin Microbiol. 2021;59(5):e02881-e02820.
-
- Tsang NNY, So HC, Ng KY, Cowling BJ, Leung GM, Ip DKM. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Online. 2021;21:1233-1245. doi:10.1016/S1473-3099(21)00146-8
-
- World Health Organization. Recommendations for National SARS-CoV-2 Testing Strategies and Diagnostic Capacities (Interim Guidance). World Health Organization; 2021. Published online June 25, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-lab-testing-2021.1...
-
- Centers for Disease Control and Prevention. Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing. Centers for Disease Control and Prevention; 2021. Published July 15, 2022. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specim...
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous